Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the development of a new class of potent, oral core inhibitor drug candidates, Assem... Read more
REVOLUTION Medicines
19 followers
4D Molecular Therapeutics
8 followers
Kymera Therapeutics
7 followers
Dyne Therapeutics
6 followers
Stemline Therapeutics
4 followers
Arcutis Biotherapeutics
3 followers
Biosynth
3 followers
Viridian Therapeutics
2 followers
RayzeBio
2 followers
Terray Therapeutics
2 followers
Bicara Therapeutics
2 followers
Vibrant Wellness
2 followers